Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.

1 report, 1 independent Updated Aug 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Moderna Memorial Sloan Kettering Cancer Center American Cancer Society

Keep exploring

Part of

Memorial Sloan Kettering Cancer Center and the American Cancer Society are involved in cancer care, with Martin Voss serving as the oncologist at the center in New York City. All 1 developments

The entities involved

Moderna
American biotechnology company
- MarketBeat listed Regeneron Pharmaceuticals, AbbVie, and Moderna as stocks to watch on October 31, 2026.Sat 16:45
- The European Medicines Agency is reviewing mRNA vaccine trials reported by Moderna and MSD.Sat 03:31
Memorial Sloan Kettering Cancer Center
cancer treatment and research institution in New York City, United States
- MSKCC director Rudin presented trial data involving Amgen on October 25, 2026.Sun 17:06
American Cancer Society
health organization seeking to cure and treat cancer
- Gas samples from New England were analyzed for toxins, linking benzene exposure to cancer risks amid high energy costs.Thu 17:01
- The American Cancer Society released estimates regarding annual mesothelioma diagnoses in the United States.Thu 06:10

Related events

Coverage

Newest first; wire copies grouped

Aug 27finchannel.com